Connection

Kent Armeson to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Kent Armeson has written about Carcinoma, Non-Small-Cell Lung.
Kent Armeson
Connection Strength
0.244
Carcinoma, Non-Small-Cell Lung
  1. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
    View in: PubMed
    Score: 0.136
  2. The neuropilin 2 isoform NRP2b uniquely supports TGF?-mediated progression in lung cancer. Sci Signal. 2017 01 17; 10(462).
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.